These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
¨
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Maryland
|
|
27-0467113
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
|
|
|
|
|
|
|
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
¨
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
Assets:
|
|
|
|
||||
|
Cash
|
$
|
140,229
|
|
|
$
|
200,996
|
|
|
Restricted cash
|
76
|
|
|
62,457
|
|
||
|
Securities, at estimated fair value
|
191,902
|
|
|
331,076
|
|
||
|
Securities, held-to-maturity
|
—
|
|
|
146,352
|
|
||
|
Commercial mortgage loans, held for investment, net
|
2,218,222
|
|
|
1,641,856
|
|
||
|
Subordinate loans, held for investment, net
|
1,340,378
|
|
|
1,051,236
|
|
||
|
Investment in unconsolidated joint venture
|
—
|
|
|
22,103
|
|
||
|
Derivative assets, net
|
—
|
|
|
5,906
|
|
||
|
Interest receivable
|
27,895
|
|
|
19,281
|
|
||
|
Other assets, net
|
14,240
|
|
|
1,714
|
|
||
|
Total Assets
|
$
|
3,932,942
|
|
|
$
|
3,482,977
|
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Borrowings under repurchase agreements (net of deferred financing costs of $10,884 and $6,763 in 2017 and 2016, respectively)
|
$
|
1,278,631
|
|
|
$
|
1,139,803
|
|
|
Convertible senior notes, net
|
471,911
|
|
|
249,994
|
|
||
|
Participations sold
|
—
|
|
|
84,979
|
|
||
|
Derivative liabilities, net
|
11,746
|
|
|
—
|
|
||
|
Accounts payable, accrued expenses and other liabilities
|
8,852
|
|
|
17,681
|
|
||
|
Payable to related party
|
8,309
|
|
|
7,015
|
|
||
|
Dividends payable
|
55,916
|
|
|
51,278
|
|
||
|
Total Liabilities
|
1,835,365
|
|
|
1,550,750
|
|
||
|
Commitments and Contingencies (see Note 14)
|
|
|
|
||||
|
Stockholders’ Equity:
|
|
|
|
||||
|
Preferred stock, $0.01 par value, 50,000,000 shares authorized:
|
|
|
|
||||
|
Series A preferred stock, 0 and 3,450,000 shares issued and outstanding ($0 and $86,250 aggregate liquidation preference) in 2017 and 2016, respectively
|
—
|
|
|
35
|
|
||
|
Series B preferred stock, 8,000,000 shares issued and outstanding ($200,000 aggregate liquidation preference) in 2017 and 2016
|
80
|
|
|
80
|
|
||
|
Series C preferred stock, 6,900,000 shares issued and outstanding ($172,500 aggregate liquidation preference) in 2017 and 2016
|
69
|
|
|
69
|
|
||
|
Common stock, $0.01 par value, 450,000,000 shares authorized, 105,451,235 and 91,422,676 shares issued and outstanding in 2017 and 2016, respectively
|
1,055
|
|
|
914
|
|
||
|
Additional paid-in-capital
|
2,163,539
|
|
|
1,983,010
|
|
||
|
Accumulated deficit
|
(67,166
|
)
|
|
(48,070
|
)
|
||
|
Accumulated other comprehensive loss
|
—
|
|
|
(3,811
|
)
|
||
|
Total Stockholders’ Equity
|
2,097,577
|
|
|
1,932,227
|
|
||
|
Total Liabilities and Stockholders’ Equity
|
$
|
3,932,942
|
|
|
$
|
3,482,977
|
|
|
|
Three months ended
September 30, |
|
Nine months ended
September 30, |
||||||||||
|
|
2017
|
2016
|
|
2017
|
2016
|
||||||||
|
Net interest income:
|
|
|
|
|
|
||||||||
|
Interest income from securities
|
$
|
2,625
|
|
$
|
8,029
|
|
|
$
|
9,247
|
|
$
|
23,685
|
|
|
Interest income from securities, held to maturity
|
—
|
|
2,875
|
|
|
4,132
|
|
8,597
|
|
||||
|
Interest income from commercial mortgage loans
|
41,203
|
|
27,460
|
|
|
112,690
|
|
72,727
|
|
||||
|
Interest income from subordinate loans
|
47,268
|
|
32,207
|
|
|
121,298
|
|
89,649
|
|
||||
|
Interest expense
|
(19,855
|
)
|
(17,256
|
)
|
|
(56,089
|
)
|
(47,620
|
)
|
||||
|
Net interest income
|
71,241
|
|
53,315
|
|
|
191,278
|
|
147,038
|
|
||||
|
Operating expenses:
|
|
|
|
|
|
||||||||
|
General and administrative expenses (includes $2,635 and $9,887 of equity based compensation in 2017 and $1,828 and $5,434 of equity compensation in 2016, respectively)
|
(4,629
|
)
|
(8,352
|
)
|
|
(15,587
|
)
|
(21,456
|
)
|
||||
|
Management fees to related party
|
(8,309
|
)
|
(5,903
|
)
|
|
(23,484
|
)
|
(16,374
|
)
|
||||
|
Total operating expenses
|
(12,938
|
)
|
(14,255
|
)
|
|
(39,071
|
)
|
(37,830
|
)
|
||||
|
Income (loss) from unconsolidated joint venture
|
—
|
|
80
|
|
|
(2,847
|
)
|
207
|
|
||||
|
Other income
|
359
|
|
309
|
|
|
710
|
|
334
|
|
||||
|
Provision for loan losses and impairments
|
—
|
|
—
|
|
|
(5,000
|
)
|
(15,000
|
)
|
||||
|
Realized loss on sale of assets
|
(4,076
|
)
|
(225
|
)
|
|
(5,118
|
)
|
(225
|
)
|
||||
|
Unrealized gain (loss) on securities
|
13,488
|
|
(9,798
|
)
|
|
11,830
|
|
(36,601
|
)
|
||||
|
Foreign currency gain (loss)
|
7,763
|
|
(4,369
|
)
|
|
17,848
|
|
(21,926
|
)
|
||||
|
Bargain purchase gain
|
—
|
|
40,021
|
|
|
—
|
|
40,021
|
|
||||
|
Gain (loss) on derivative instruments (includes unrealized gains (losses) of ($7,302) and ($17,626) in 2017 and ($10,297) and $1,731 in 2016, respectively)
|
(7,481
|
)
|
4,815
|
|
|
(17,916
|
)
|
22,831
|
|
||||
|
Net income
|
68,356
|
|
69,893
|
|
|
151,714
|
|
98,849
|
|
||||
|
Preferred dividends
|
$
|
(11,148
|
)
|
$
|
(9,310
|
)
|
|
$
|
(29,768
|
)
|
$
|
(20,985
|
)
|
|
Net income available to common stockholders
|
57,208
|
|
60,583
|
|
|
121,946
|
|
77,864
|
|
||||
|
Basic and diluted net income per share of common stock
|
$
|
0.54
|
|
$
|
0.83
|
|
|
$
|
1.23
|
|
$
|
1.11
|
|
|
Basic weighted average shares of common stock outstanding
|
105,446,704
|
|
71,919,549
|
|
|
97,546,437
|
|
68,913,362
|
|
||||
|
Diluted weighted average shares of common stock outstanding
|
106,812,721
|
|
72,861,611
|
|
|
98,919,689
|
|
69,865,603
|
|
||||
|
Dividend declared per share of common stock
|
$
|
0.46
|
|
$
|
0.46
|
|
|
$
|
1.38
|
|
$
|
1.38
|
|
|
|
Three months ended
September 30, |
|
Nine months ended
September 30, |
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Net income available to common stockholders
|
$
|
57,208
|
|
|
$
|
60,583
|
|
|
$
|
121,946
|
|
|
$
|
77,864
|
|
|
Foreign currency translation adjustment
|
—
|
|
|
73
|
|
|
3,811
|
|
|
499
|
|
||||
|
Comprehensive income
|
$
|
57,208
|
|
|
$
|
60,656
|
|
|
$
|
125,757
|
|
|
$
|
78,363
|
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid In
Capital
|
|
Retained
Earnings
(Accumulated
Deficit)
|
|
Accumulated
Other
Comprehensive
Loss
|
|
|
||||||||||||||||||
|
|
Shares
|
|
Par
|
|
Shares
|
|
Par
|
|
|
|
|
Total
|
|||||||||||||||||
|
Balance at January 1, 2017
|
18,350,000
|
|
|
$
|
184
|
|
|
91,422,676
|
|
|
$
|
914
|
|
|
$
|
1,983,010
|
|
|
$
|
(48,070
|
)
|
|
$
|
(3,811
|
)
|
|
$
|
1,932,227
|
|
|
Capital increase related to Equity Incentive Plan
|
—
|
|
|
—
|
|
|
200,859
|
|
|
3
|
|
|
7,551
|
|
|
—
|
|
|
—
|
|
|
7,554
|
|
||||||
|
Issuance of common stock
|
—
|
|
|
—
|
|
|
13,800,000
|
|
|
138
|
|
|
248,883
|
|
|
—
|
|
|
—
|
|
|
249,021
|
|
||||||
|
Redemption of preferred stock
|
(3,450,000
|
)
|
|
(35
|
)
|
|
—
|
|
|
—
|
|
|
(86,215
|
)
|
|
—
|
|
|
—
|
|
|
(86,250
|
)
|
||||||
|
Preferred stock redemption charge
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,016
|
|
|
—
|
|
|
—
|
|
|
3,016
|
|
||||||
|
Issuance of restricted common stock
|
—
|
|
|
—
|
|
|
27,700
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(120
|
)
|
|
—
|
|
|
—
|
|
|
(120
|
)
|
||||||
|
Issuance of convertible senior notes
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,414
|
|
|
—
|
|
|
—
|
|
|
7,414
|
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
151,714
|
|
|
—
|
|
|
151,714
|
|
||||||
|
Change in other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,811
|
|
|
3,811
|
|
||||||
|
Dividends on common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(141,042
|
)
|
|
—
|
|
|
(141,042
|
)
|
||||||
|
Dividends on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(29,768
|
)
|
|
—
|
|
|
(29,768
|
)
|
||||||
|
Balance at September 30, 2017
|
14,900,000
|
|
|
$
|
149
|
|
|
105,451,235
|
|
|
$
|
1,055
|
|
|
$
|
2,163,539
|
|
|
$
|
(67,166
|
)
|
|
$
|
—
|
|
|
$
|
2,097,577
|
|
|
|
Nine months ended September 30, 2017
|
|
Nine months ended September 30, 2016
|
||||
|
Cash flows provided by operating activities:
|
|
|
|
||||
|
Net income
|
$
|
151,714
|
|
|
$
|
98,849
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
|
|
|
||||
|
Amortization of discount/premium and PIK interest
|
(15,491
|
)
|
|
(7,443
|
)
|
||
|
Amortization of deferred financing costs
|
4,464
|
|
|
3,199
|
|
||
|
Equity-based compensation
|
7,551
|
|
|
2,808
|
|
||
|
Unrealized (gain) loss on securities
|
(11,830
|
)
|
|
36,601
|
|
||
|
Provision for loan losses and impairment
|
5,000
|
|
|
15,000
|
|
||
|
Income (loss) from unconsolidated joint venture
|
2,259
|
|
|
(207
|
)
|
||
|
Foreign currency (gain) loss
|
(16,940
|
)
|
|
21,122
|
|
||
|
Realized (gain) loss on derivative instruments
|
289
|
|
|
(21,100
|
)
|
||
|
Unrealized (gain) loss on derivative instruments
|
17,564
|
|
|
(1,731
|
)
|
||
|
Realized loss on sale of securities
|
5,118
|
|
|
225
|
|
||
|
Bargain purchase gain
|
—
|
|
|
(40,021
|
)
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accrued interest receivable, less purchased interest
|
(27,910
|
)
|
|
(17,638
|
)
|
||
|
Other assets
|
(983
|
)
|
|
(121
|
)
|
||
|
Accounts payable, accrued expenses and other liabilities
|
(8,623
|
)
|
|
(10,410
|
)
|
||
|
Payable to related party
|
1,295
|
|
|
606
|
|
||
|
Net cash provided by operating activities
|
113,477
|
|
|
79,739
|
|
||
|
Cash flows provided by (used in) investing activities:
|
|
|
|
||||
|
Funding of commercial mortgage loans
|
(581,567
|
)
|
|
(548,171
|
)
|
||
|
Funding of subordinate loans
|
(475,503
|
)
|
|
(51,921
|
)
|
||
|
Payments received on commercial mortgage loans
|
17,062
|
|
|
118,120
|
|
||
|
Payments received on subordinate loans
|
221,478
|
|
|
81,524
|
|
||
|
Origination and exit fees received on commercial mortgage loans and subordinate loans
|
13,047
|
|
|
7,509
|
|
||
|
Funding of unconsolidated joint venture
|
(726
|
)
|
|
(362
|
)
|
||
|
Funding of other assets
|
(1,379
|
)
|
|
—
|
|
||
|
Proceeds (payments) on settlements of derivative instruments
|
(201
|
)
|
|
21,100
|
|
||
|
Decrease (Increase) in collateral held related to derivative contracts
|
(14,262
|
)
|
|
13,110
|
|
||
|
Proceeds from sale of securities
|
128,945
|
|
|
86,451
|
|
||
|
Proceeds from sale of investment in unconsolidated joint venture
|
24,498
|
|
|
—
|
|
||
|
Payments received on securities
|
13,306
|
|
|
22,424
|
|
||
|
Payments received on securities, held-to-maturity
|
146,530
|
|
|
5,970
|
|
||
|
Payments received on other assets
|
—
|
|
|
107
|
|
||
|
Proceeds from sale of AMTG assets, net
|
—
|
|
|
1,474,111
|
|
||
|
ARI Investment in AMTG, net of cash acquired
|
—
|
|
|
189,795
|
|
||
|
Net cash provided by (used in) investing activities
|
(508,772
|
)
|
|
1,419,767
|
|
||
|
Cash flows provided by (used in) financing activities:
|
|
|
|
||||
|
Proceeds from issuance of common stock
|
249,021
|
|
|
—
|
|
||
|
Redemption of Series A preferred stock
|
(86,250
|
)
|
|
—
|
|
||
|
Payment of offering costs
|
(359
|
)
|
|
(45
|
)
|
||
|
Proceeds from repurchase agreement borrowings
|
866,548
|
|
|
448,177
|
|
||
|
Repayments of repurchase agreement borrowings
|
(727,691
|
)
|
|
(352,914
|
)
|
||
|
Repayments of AMTG repurchase agreement borrowings
|
—
|
|
|
(1,254,517
|
)
|
||
|
Proceeds from issuance of convertible senior notes
|
227,700
|
|
|
—
|
|
||
|
Repayments of participations sold
|
(85,081
|
)
|
|
(3,770
|
)
|
||
|
Payment of deferred financing costs
|
(8,585
|
)
|
|
(3,741
|
)
|
||
|
Dividends on common stock
|
(136,404
|
)
|
|
(94,625
|
)
|
||
|
Dividends on preferred stock
|
(26,752
|
)
|
|
(18,646
|
)
|
||
|
Net cash provided by (used in) financing activities
|
272,147
|
|
|
(1,280,081
|
)
|
||
|
Net increase (decrease) in cash, cash equivalents, and restricted cash
|
(123,148
|
)
|
|
219,425
|
|
||
|
Cash, cash equivalents, and restricted cash, beginning of period
|
263,453
|
|
|
97,542
|
|
||
|
Cash, cash equivalents, and restricted cash, end of period
|
$
|
140,305
|
|
|
$
|
316,967
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Interest paid
|
$
|
44,303
|
|
|
$
|
47,093
|
|
|
Supplemental disclosure of non-cash investing and financing activities:
|
|
|
|
||||
|
Dividend declared, not yet paid
|
$
|
55,916
|
|
|
$
|
46,028
|
|
|
Deferred financing costs, not yet paid
|
$
|
—
|
|
|
$
|
—
|
|
|
Offering costs payable
|
$
|
41
|
|
|
$
|
220
|
|
|
Fair value of assets acquired from AMTG
|
$
|
—
|
|
|
$
|
1,936
|
|
|
Fair value of liabilities assumed from AMTG
|
$
|
—
|
|
|
$
|
(1,285
|
)
|
|
Fair value of common stock issued to AMTG
|
$
|
—
|
|
|
$
|
218
|
|
|
Fair value of preferred stock issued to AMTG
|
$
|
—
|
|
|
$
|
173
|
|
|
|
Nine months ended September 30,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Cash and cash equivalents
|
$
|
140,229
|
|
|
$
|
254,643
|
|
|
Restricted cash
|
76
|
|
|
62,324
|
|
||
|
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows
|
$
|
140,305
|
|
|
$
|
316,967
|
|
|
|
Fair Value as of September 30, 2017
|
|
Fair Value as of December 31, 2016
|
||||||||||||||||||||||||||||
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||||||||||
|
CMBS (Fair Value Option)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
191,902
|
|
|
$
|
191,902
|
|
|
$
|
—
|
|
|
$
|
331,076
|
|
|
$
|
—
|
|
|
$
|
331,076
|
|
|
Derivative instruments, net
|
—
|
|
|
(11,746
|
)
|
|
—
|
|
|
(11,746
|
)
|
|
—
|
|
|
5,906
|
|
|
—
|
|
|
5,906
|
|
||||||||
|
Total
|
$
|
—
|
|
|
$
|
(11,746
|
)
|
|
$
|
191,902
|
|
|
$
|
180,156
|
|
|
$
|
—
|
|
|
$
|
336,982
|
|
|
$
|
—
|
|
|
$
|
336,982
|
|
|
|
|
CMBS
|
||
|
Fair value at December 31, 2016
|
|
$
|
—
|
|
|
Transfers into Level III
(1)
|
|
254,484
|
|
|
|
Net realized loss on investments
|
|
(4,076
|
)
|
|
|
Net increase in unrealized gain on investments
|
|
13,488
|
|
|
|
Sales and repayments of investments
|
|
(71,073
|
)
|
|
|
Amortization of purchase discount, net
|
|
(921
|
)
|
|
|
Fair value at September 30, 2017
|
|
$
|
191,902
|
|
|
|
|
|
|
|
|
Unobservable Input
|
|||
|
Asset Category
|
|
Fair Value
|
|
Primary Valuation Technique
|
|
Input
|
|
Range
|
|
|
CMBS
|
|
191,902
|
|
|
Broker quotes
|
|
Price
(1)
|
|
63 - 101
|
|
Security Description
|
Face
Amount
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gain
|
|
Gross
Unrealized
Loss
|
|
Estimated Fair
Value
|
||||||||||
|
CMBS (Fair Value Option)
|
$
|
222,522
|
|
|
$
|
217,242
|
|
|
$
|
247
|
|
|
$
|
(25,587
|
)
|
|
$
|
191,902
|
|
|
Security Description
|
Face
Amount
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gain
|
|
Gross
Unrealized
Loss
|
|
Estimated
Fair
Value
|
||||||||||
|
CMBS (Fair Value Option)
|
$
|
375,861
|
|
|
$
|
368,247
|
|
|
$
|
292
|
|
|
$
|
(37,463
|
)
|
|
$
|
331,076
|
|
|
CMBS (Held-to-Maturity)
|
146,530
|
|
|
146,352
|
|
|
—
|
|
|
—
|
|
|
146,352
|
|
|||||
|
Total
|
$
|
522,391
|
|
|
$
|
514,599
|
|
|
$
|
292
|
|
|
$
|
(37,463
|
)
|
|
$
|
477,428
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||
|
Credit Ratings *
|
BB-D
|
|
|
B+-NR
|
|
|
Coupon
|
5.9
|
%
|
|
5.9
|
%
|
|
Yield
|
4.2
|
%
|
|
6.0
|
%
|
|
Weighted Average Life
|
2.0 years
|
|
|
2.5 years
|
|
|
*
|
Ratings per Fitch Ratings, Moody’s Investors Service or Standard & Poor's.
|
|
Vintage
|
September 30, 2017
|
|
December 31, 2016
|
||
|
2005
|
—
|
%
|
|
2.0
|
%
|
|
2006
|
21.2
|
|
|
12.1
|
|
|
2007
|
57.0
|
|
|
73.5
|
|
|
2008
|
21.8
|
|
|
12.4
|
|
|
Total
|
100.0
|
%
|
|
100.0
|
%
|
|
Property Type
|
September 30, 2017
|
|
December 31, 2016
|
||
|
Office
|
37.8
|
%
|
|
34.6
|
%
|
|
Retail
|
25.8
|
|
|
29.0
|
|
|
Multifamily
|
13.6
|
|
|
12.4
|
|
|
Other
(1)
|
22.8
|
|
|
24.0
|
|
|
Total
|
100.0
|
%
|
|
100.0
|
%
|
|
Location
|
September 30, 2017
|
|
December 31, 2016
|
||
|
South Atlantic
|
28.3
|
%
|
|
23.8
|
%
|
|
Middle Atlantic
|
11.9
|
|
|
16.7
|
|
|
Pacific
|
5.8
|
|
|
15.3
|
|
|
East North Central
|
16.7
|
|
|
10.8
|
|
|
Other
(1)
|
37.3
|
|
|
33.4
|
|
|
Total
|
100.0
|
%
|
|
100.0
|
%
|
|
Loan Type
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
Commercial mortgage loans, held for investment, net
|
|
$
|
2,218,222
|
|
|
$
|
1,641,856
|
|
|
Subordinate loans, held for investment, net
|
|
1,340,378
|
|
|
1,051,236
|
|
||
|
Total loans, held for investment, net
|
|
$
|
3,558,600
|
|
|
$
|
2,693,092
|
|
|
|
|
Principal Balance
|
|
Deferred Fees/Other Items
(1)
|
|
Provision for Loan Loss
(2)
|
|
Carrying Value
|
||||
|
December 31, 2016
|
|
2,720,344
|
|
|
(12,252
|
)
|
|
(15,000
|
)
|
|
2,693,092
|
|
|
Loan fundings
|
|
1,057,070
|
|
|
—
|
|
|
—
|
|
|
1,057,070
|
|
|
Loan repayments
|
|
(238,541
|
)
|
|
—
|
|
|
—
|
|
|
(238,541
|
)
|
|
Unrealized gain on foreign currency translation
|
|
20,974
|
|
|
—
|
|
|
—
|
|
|
20,974
|
|
|
Provision for loan loss
(2)
|
|
—
|
|
|
—
|
|
|
(1,981
|
)
|
|
(1,981
|
)
|
|
Deferred fees and other items
(1)
|
|
—
|
|
|
(13,047
|
)
|
|
—
|
|
|
(13,047
|
)
|
|
PIK interest, amortization of fees and other items
(1)
|
|
19,321
|
|
|
21,712
|
|
|
—
|
|
|
41,033
|
|
|
September 30, 2017
|
|
3,579,168
|
|
|
(3,587
|
)
|
|
(16,981
|
)
|
|
3,558,600
|
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
Number of loans
|
|
56
|
|
|
45
|
|
||
|
Principal balance
|
|
$
|
3,579,168
|
|
|
$
|
2,720,344
|
|
|
Carrying value
|
|
$
|
3,558,600
|
|
|
$
|
2,693,092
|
|
|
Unfunded loan commitments
(1)
|
|
$
|
80,164
|
|
|
$
|
170,365
|
|
|
Weighted-average cash coupon
(2)
|
|
8.5
|
%
|
|
8.88
|
%
|
||
|
(1)
|
Unfunded loan commitments are primarily funded to finance property improvements or lease-related expenditures by the borrowers. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.
|
|
(2)
|
For floating rate loans, assumes one-month LIBOR of
1.23%
and
0.77%
, as of
September 30, 2017
and
December 31, 2016
, respectively.
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||
|
Property Type
|
|
Carrying
Value |
|
% of
Portfolio |
|
Carrying
Value |
|
% of
Portfolio |
||||
|
Residential - for sale
|
|
735,551
|
|
|
20.7
|
%
|
|
469,997
|
|
|
17.5
|
%
|
|
Hotel
|
|
652,745
|
|
|
18.3
|
%
|
|
408,428
|
|
|
15.2
|
%
|
|
Urban Retail Predevelopment
|
|
644,283
|
|
|
18.1
|
%
|
|
491,187
|
|
|
18.2
|
%
|
|
Mixed Use
|
|
352,094
|
|
|
9.9
|
%
|
|
134,797
|
|
|
5.0
|
%
|
|
Office
|
|
293,093
|
|
|
8.2
|
%
|
|
255,031
|
|
|
9.5
|
%
|
|
Residential Rental
|
|
278,117
|
|
|
7.8
|
%
|
|
309,243
|
|
|
11.5
|
%
|
|
Retail Center
|
|
197,120
|
|
|
5.5
|
%
|
|
209,401
|
|
|
7.8
|
%
|
|
Healthcare
|
|
174,244
|
|
|
4.9
|
%
|
|
170,549
|
|
|
6.3
|
%
|
|
Other
|
|
154,017
|
|
|
4.3
|
%
|
|
87,650
|
|
|
3.3
|
%
|
|
Industrial
|
|
77,336
|
|
|
2.3
|
%
|
|
156,809
|
|
|
5.7
|
%
|
|
|
|
3,558,600
|
|
|
100.0
|
%
|
|
2,693,092
|
|
|
100.0
|
%
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
Geographic Location
|
|
Carrying
Value |
|
% of
Portfolio |
|
Carrying
Value |
|
% of
Portfolio |
|
Manhattan, NY
|
|
$1,246,235
|
|
35.0%
|
|
$870,914
|
|
32.3%
|
|
Brooklyn, NY
|
|
244,501
|
|
6.9%
|
|
163,389
|
|
6.1%
|
|
Northeast
|
|
133,979
|
|
3.8%
|
|
137,770
|
|
5.1%
|
|
Southeast
|
|
530,881
|
|
14.9%
|
|
332,276
|
|
12.3%
|
|
Midwest
|
|
524,984
|
|
14.7%
|
|
405,992
|
|
15.1%
|
|
Mid Atlantic
|
|
248,786
|
|
7.0%
|
|
263,717
|
|
9.8%
|
|
West
|
|
205,274
|
|
5.8%
|
|
219,664
|
|
8.2%
|
|
Southwest
|
|
33,824
|
|
1.0%
|
|
54,614
|
|
2.0%
|
|
United Kingdom
|
|
312,159
|
|
8.7%
|
|
244,756
|
|
9.1%
|
|
Other International
|
|
77,977
|
|
2.2%
|
|
—
|
|
—%
|
|
Total
|
|
$3,558,600
|
|
100%
|
|
$2,693,092
|
|
100%
|
|
|
September 30, 2017
|
|
|
December 31, 2016
|
||||||||||||||||||||||
|
Lender
|
Maximum Amount of Borrowings
|
|
Borrowings Outstanding
|
|
Maturity
(1)
|
|
Weighted
Average Rate (2) |
|
|
Maximum Amount of Borrowings
|
|
Borrowings Outstanding
|
|
Maturity
(1)
|
|
Weighted
Average Rate (2) |
||||||||||
|
JPMorgan Facility
(3)
|
$
|
1,118,000
|
|
|
$
|
840,360
|
|
|
March 2020
|
|
L+2.27%
|
|
|
|
$
|
943,000
|
|
|
$
|
657,452
|
|
|
January 2019
|
|
L+2.25%
|
|
|
DB Repurchase Facility
(4)
|
565,491
|
|
|
265,658
|
|
|
March 2020
|
|
L+2.35%
|
|
|
|
300,000
|
|
|
137,355
|
|
|
September 2019
|
|
L+2.66%
|
|
||||
|
Goldman Loan
|
34,180
|
|
|
34,180
|
|
|
April 2019
|
|
L+3.50%
|
|
|
|
N/A
|
|
|
40,657
|
|
|
April 2019
|
|
L+3.50%
|
|
||||
|
Sub-total
|
1,717,671
|
|
|
1,140,198
|
|
|
|
|
L+2.32%
|
|
|
|
|
|
|
835,464
|
|
|
|
|
L+2.38%
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
UBS Facility
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
N/A
|
|
|
|
N/A
|
|
|
133,899
|
|
|
September 2018
|
|
2.79
|
%
|
||||
|
DB Facility
(5)
|
300,000
|
|
|
149,317
|
|
|
April 2018
|
|
3.48
|
%
|
|
|
N/A
|
|
|
177,203
|
|
|
April 2018
|
|
3.63
|
%
|
||||
|
Sub-total
|
300,000
|
|
|
149,317
|
|
|
|
|
3.48
|
%
|
|
|
|
|
|
311,102
|
|
|
|
|
3.27
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Less: deferred financing costs
|
N/A
|
|
|
(10,884
|
)
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
(6,763
|
)
|
|
|
|
N/A
|
|
||||
|
Total / Weighted Average
|
$
|
2,017,671
|
|
|
$
|
1,278,631
|
|
|
|
|
3.55
|
%
|
|
|
|
|
|
$
|
1,139,803
|
|
|
|
|
3.18
|
%
|
|
|
|
Less than
1 year
(1)
|
|
1 to 3
years
(1)
|
|
3 to 5
years
|
|
More than
5 years
|
|
Total
|
||||||||||
|
JPMorgan Facility
|
$
|
166,273
|
|
|
$
|
674,087
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
840,360
|
|
|
DB Repurchase Facility
|
—
|
|
|
265,658
|
|
|
—
|
|
|
—
|
|
|
265,658
|
|
|||||
|
Goldman Loan
|
—
|
|
|
34,180
|
|
|
—
|
|
|
—
|
|
|
34,180
|
|
|||||
|
DB Facility
|
149,317
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
149,317
|
|
|||||
|
Total
|
$
|
315,590
|
|
|
$
|
973,925
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,289,515
|
|
|
|
|
|
For the nine months ended September 30, 2017
|
||||||||
|
|
Balance at September 30, 2017
|
|
Maximum Month-End
Balance
|
|
Average Month-End
Balance
|
||||||
|
JPMorgan Facility borrowings
|
$
|
840,360
|
|
|
$
|
986,611
|
|
|
$
|
849,355
|
|
|
DB Repurchase Facility borrowings
|
265,658
|
|
|
367,010
|
|
|
286,326
|
|
|||
|
Goldman Loan borrowings
|
34,180
|
|
|
39,590
|
|
|
37,554
|
|
|||
|
DB Facility borrowings
|
149,317
|
|
|
177,203
|
|
|
136,930
|
|
|||
|
Total
|
$
|
1,289,515
|
|
|
|
|
|
||||
|
|
Principal Amount
|
Coupon Rate
|
Effective Rate
(1)
|
Conversion Rate
(2)
|
Maturity Date
|
Remaining Period of Amortization
|
|
March 2019 Notes
|
$143,750
|
5.50%
|
6.25%
|
57.3034
|
3/15/2019
|
1.46 years
|
|
August 2019 Notes
|
$111,000
|
5.50%
|
6.50%
|
57.3034
|
3/15/2019
|
1.46 years
|
|
August 2022 Notes
|
$230,000
|
4.75%
|
5.72%
|
50.2260
|
8/23/2022
|
4.90 years
|
|
(1)
|
Effective rate includes the effect of the adjustment for the conversion option (see footnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.
|
|
(2)
|
The Company has the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per
$1,000
principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by the Company to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.
|
|
Type of Derivative
|
September 30, 2017
|
||||||
|
|
Number of Contracts
|
|
Aggregate Notional Amount
|
|
Notional Currency
|
|
Maturity
|
|
Fx Contracts - GBP
|
13
|
|
197,401
|
|
GBP
|
|
October 2017- April 2018
|
|
Type of Derivative
|
December 31, 2016
|
||||||
|
|
Number of Contracts
|
|
Aggregate Notional Amount
|
|
Notional Currency
|
|
Maturity
|
|
Fx Contracts - GBP
|
11
|
|
148,310
|
|
GBP
|
|
January 2017- December 2017
|
|
|
|
Three months ended September 30,
|
|
Nine months ended September 30,
|
||||||||||||
|
|
Location of Loss Recognized in Income
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Forward currency contract
|
Gain (loss) on derivative instruments - unrealized
|
$
|
(7,308
|
)
|
|
$
|
(10,304
|
)
|
|
$
|
(17,629
|
)
|
|
$
|
1,812
|
|
|
Forward currency contract
|
Gain (loss) on derivative instruments - realized
|
(179
|
)
|
|
15,112
|
|
|
(290
|
)
|
|
21,100
|
|
||||
|
Interest rate caps
(1)
|
Gain (loss) on derivative instruments - unrealized
|
6
|
|
|
7
|
|
|
3
|
|
|
(81
|
)
|
||||
|
Sub-total
|
|
$
|
(7,481
|
)
|
|
$
|
4,815
|
|
|
$
|
(17,916
|
)
|
|
$
|
22,831
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Forward currency contract
|
Income (loss) from unconsolidated joint venture
|
—
|
|
|
—
|
|
|
(587
|
)
|
|
—
|
|
||||
|
Total
|
|
$
|
(7,481
|
)
|
|
$
|
4,815
|
|
|
$
|
(18,503
|
)
|
|
$
|
22,831
|
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||||||||||
|
|
Gross
Amount of Recognized Liabilities |
|
Gross
Amounts Offset in the Condensed Consolidated Balance Sheet |
|
Net Amounts
of Liabilities Presented in the Condensed Consolidated Balance Sheet |
|
Gross
Amount of Recognized Assets |
|
Gross
Amounts Offset in the Consolidated Balance Sheet |
|
Net Amounts
of Assets Presented in the Consolidated Balance Sheet |
||||||||||||
|
Interest rate caps
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
1
|
|
|
$
|
23
|
|
|
$
|
—
|
|
|
$
|
23
|
|
|
Forward currency contract
|
(11,747
|
)
|
|
—
|
|
|
(11,747
|
)
|
|
5,883
|
|
|
—
|
|
|
5,883
|
|
||||||
|
Total derivative instruments
|
$
|
(11,747
|
)
|
|
$
|
1
|
|
|
$
|
(11,746
|
)
|
|
$
|
5,906
|
|
|
$
|
—
|
|
|
$
|
5,906
|
|
|
|
Type
|
Date
|
|
Restricted Stock
|
|
RSUs
|
|
Estimated Fair Value
on Grant Date |
|
Initial Vesting
|
|
Final Vesting
|
||||
|
Outstanding at December 31, 2016
|
|
150,110
|
|
|
1,703,775
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Canceled upon delivery
|
January 2017
|
|
—
|
|
|
(332,349
|
)
|
|
n/a
|
|
|
n/a
|
|
n/a
|
|
|
|
Vested
|
January 2017
|
|
(5,161
|
)
|
|
—
|
|
|
n/a
|
|
|
n/a
|
|
n/a
|
|
|
|
Forfeiture
|
March 2017
|
|
—
|
|
|
(1,971
|
)
|
|
n/a
|
|
|
n/a
|
|
n/a
|
|
|
|
Vested
|
April 2017
|
|
(5,164
|
)
|
|
|
|
n/a
|
|
|
n/a
|
|
n/a
|
||
|
|
Grant
|
April 2017
|
|
14,674
|
|
|
—
|
|
|
$
|
275
|
|
|
April 2018
|
|
April 2020
|
|
|
Canceled upon delivery
|
May 2017
|
|
—
|
|
|
(1,971
|
)
|
|
n/a
|
|
|
n/a
|
|
n/a
|
|
|
|
Vested
|
July 2017
|
|
(4,004
|
)
|
|
|
|
n/a
|
|
|
n/a
|
|
n/a
|
||
|
|
Canceled upon delivery
|
July 2017
|
|
|
|
(544
|
)
|
|
n/a
|
|
|
n/a
|
|
n/a
|
||
|
|
Grant
|
August 2017
|
|
13,026
|
|
|
|
|
$
|
233
|
|
|
August 2018
|
|
August 2018
|
|
|
|
Grant
|
August 2017
|
|
|
|
790
|
|
|
$
|
14
|
|
|
August 2018
|
|
August 2021
|
|
|
|
Forfeiture
|
September 2017
|
|
|
|
(8,273
|
)
|
|
n/a
|
|
|
n/a
|
|
n/a
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Outstanding at September 30, 2017
|
|
163,481
|
|
|
1,359,457
|
|
|
|
|
|
|
|
||||
|
Vesting Date
|
Restricted Stock Vesting
|
|
RSU Vesting
|
|
Total Awards
|
|||
|
October 2017
|
3,997
|
|
|
—
|
|
|
3,997
|
|
|
December 2017
|
53,923
|
|
|
603,677
|
|
|
657,600
|
|
|
January 2018
|
2,749
|
|
|
—
|
|
|
2,749
|
|
|
April 2018
|
7,645
|
|
|
—
|
|
|
7,645
|
|
|
June 2018
|
—
|
|
|
544
|
|
|
544
|
|
|
July 2018
|
1,420
|
|
|
—
|
|
|
1,420
|
|
|
October 2018
|
1,424
|
|
|
—
|
|
|
1,424
|
|
|
December 2018
|
41,670
|
|
|
477,173
|
|
|
518,843
|
|
|
January 2019
|
1,419
|
|
|
—
|
|
|
1,419
|
|
|
April 2019
|
6,314
|
|
|
—
|
|
|
6,314
|
|
|
December 2019
|
25,000
|
|
|
277,273
|
|
|
302,273
|
|
|
April 2020
|
4,894
|
|
|
—
|
|
|
4,894
|
|
|
August 2020
|
—
|
|
|
264
|
|
|
264
|
|
|
Total
|
163,481
|
|
|
1,359,457
|
|
|
1,522,939
|
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Per Share
|
|
March 14, 2017
|
March 31, 2017
|
April 17, 2017
|
$0.4600
|
|
June 15, 2017
|
June 30, 2017
|
July 17, 2017
|
$0.4600
|
|
September 14, 2017
|
September 29, 2017
|
October 16, 2017
|
$0.4600
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Per Share
|
|
March 14, 2017
|
March 31, 2017
|
April 17, 2017
|
$0.5391
|
|
June 15, 2017
|
June 30, 2017
|
July 17, 2017
|
$0.5391
|
|
July 3, 2017
|
August 2, 2017
|
August 2, 2017
|
$0.1079
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Per Share
|
|
March 14, 2017
|
March 31, 2017
|
April 17, 2017
|
$0.5000
|
|
June 15, 2017
|
June 30, 2017
|
July 17, 2017
|
$0.5000
|
|
September 14, 2017
|
September 29, 2017
|
October 16, 2017
|
$0.5000
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Per Share
|
|
March 14, 2017
|
March 31, 2017
|
April 28, 2017
|
$0.5000
|
|
June 15, 2017
|
June 30, 2017
|
July 31, 2017
|
$0.5000
|
|
September 14, 2017
|
September 29, 2017
|
October 31, 2017
|
$0.5000
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||||||||||
|
|
Carrying
Value
|
|
Estimated
Fair Value
|
|
Carrying
Value
|
|
Estimated
Fair Value
|
||||||||
|
Cash and cash equivalents
|
$
|
140,229
|
|
|
$
|
140,229
|
|
|
$
|
200,996
|
|
|
$
|
200,996
|
|
|
Restricted cash
|
76
|
|
|
76
|
|
|
62,457
|
|
|
62,457
|
|
||||
|
Securities, held-to-maturity
|
—
|
|
|
—
|
|
|
146,352
|
|
|
146,352
|
|
||||
|
Commercial mortgage loans
|
2,218,222
|
|
|
2,235,084
|
|
|
1,641,856
|
|
|
1,648,896
|
|
||||
|
Subordinate loans
|
1,340,378
|
|
|
1,323,249
|
|
|
1,051,236
|
|
|
1,060,882
|
|
||||
|
Borrowings under repurchase agreements
|
(1,289,515
|
)
|
|
(1,288,982
|
)
|
|
(1,146,566
|
)
|
|
(1,146,807
|
)
|
||||
|
2019 Notes
|
(251,438
|
)
|
|
(277,041
|
)
|
|
(249,994
|
)
|
|
(268,124
|
)
|
||||
|
August 2022 Notes
|
(220,473
|
)
|
|
(234,025
|
)
|
|
—
|
|
|
—
|
|
||||
|
Participations sold
|
—
|
|
|
—
|
|
|
(84,979
|
)
|
|
(85,072
|
)
|
||||
|
|
For the three
months ended September 30, |
|
For the nine
months ended September 30, |
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Numerator:
|
|
|
|
|
|
|
|
||||||||
|
Net income
|
$
|
68,356
|
|
|
$
|
69,893
|
|
|
$
|
151,714
|
|
|
$
|
98,849
|
|
|
Preferred dividends
|
(11,148
|
)
|
|
(9,310
|
)
|
|
(29,768
|
)
|
|
(20,985
|
)
|
||||
|
Net income available to common stockholders
|
57,208
|
|
|
60,583
|
|
|
121,946
|
|
|
77,864
|
|
||||
|
Dividends declared on common stock
|
(48,507
|
)
|
|
(37,180
|
)
|
|
(139,155
|
)
|
|
(99,182
|
)
|
||||
|
Dividends on participating securities
|
(625
|
)
|
|
(413
|
)
|
|
(1,884
|
)
|
|
(1,298
|
)
|
||||
|
Net income (loss) attributable to common stockholders
|
$
|
8,076
|
|
|
$
|
22,990
|
|
|
$
|
(19,093
|
)
|
|
$
|
(22,616
|
)
|
|
Denominator:
|
|
|
|
|
|
|
|
||||||||
|
Basic weighted average shares of common stock outstanding
|
105,446,704
|
|
|
71,919,549
|
|
|
97,546,437
|
|
|
68,913,362
|
|
||||
|
Diluted weighted average shares of common stock outstanding
|
106,812,721
|
|
|
72,861,611
|
|
|
98,919,689
|
|
|
69,865,603
|
|
||||
|
Basic and diluted net income per weighted average share of common stock
|
|
|
|
|
|
|
|
||||||||
|
Distributable Earnings
|
$
|
0.46
|
|
|
$
|
0.52
|
|
|
$
|
1.43
|
|
|
$
|
1.44
|
|
|
Undistributed income (loss)
|
$
|
0.08
|
|
|
$
|
0.31
|
|
|
$
|
(0.20
|
)
|
|
$
|
(0.33
|
)
|
|
Basic and diluted net income per share of common stock
|
$
|
0.54
|
|
|
$
|
0.83
|
|
|
$
|
1.23
|
|
|
$
|
1.11
|
|
|
Consideration Paid:
|
$ (in thousands)
|
|
||
|
|
Cash
|
$
|
220,159
|
|
|
|
Common stock issued
|
218,397
|
|
|
|
|
Preferred stock assumed
|
172,500
|
|
|
|
|
Total consideration paid
|
$
|
611,056
|
|
|
|
|
|
||
|
Assets acquired:
|
|
|
||
|
|
Cash and cash equivalents
|
399,402
|
|
|
|
|
Restricted cash
|
10,552
|
|
|
|
|
Investments
|
1,491,484
|
|
|
|
|
Other assets
|
34,822
|
|
|
|
|
|
|
||
|
Liabilities assumed:
|
|
|
||
|
|
Borrowings under repurchase agreements
|
(1,254,518
|
)
|
|
|
|
Other liabilities
|
(30,665
|
)
|
|
|
|
|
|
||
|
|
Net assets acquired
|
651,077
|
|
|
|
|
|
|
|
|
|
|
Bargain purchase gain
|
$
|
40,021
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
(in thousands, except per share data)
|
September 30, 2016
|
|
September 30, 2016
|
||||
|
Total revenue
|
$
|
89,665
|
|
|
$
|
280,230
|
|
|
Net income attributable to common shareholders
|
15,615
|
|
|
40,161
|
|
||
|
|
|
|
|
||||
|
Common shares outstanding at September 30, 2016
|
80,826,566
|
|
|
80,826,566
|
|
||
|
Net income per common share, basic and diluted
|
$
|
0.19
|
|
|
$
|
0.50
|
|
|
Description
|
|
Amortized
Cost |
|
Weighted Average Coupon (1)
|
|
Weighted Average All-in Yield (1)
(2) |
|
Debt
|
|
Cost of Funds
|
|
Equity at
cost |
|||||||||
|
First mortgages
|
|
$
|
2,218,222
|
|
|
6.5
|
%
|
|
7.3
|
%
|
|
$
|
1,140,198
|
|
|
3.6
|
%
|
|
$
|
1,078,024
|
|
|
Subordinate loans
|
|
1,340,378
|
|
|
11.8
|
|
|
13.1
|
|
|
—
|
|
|
—
|
|
|
1,340,378
|
|
|||
|
Total/Weighted Average
|
|
$
|
3,558,600
|
|
|
8.5
|
%
|
|
9.5
|
%
|
|
$
|
1,140,198
|
|
|
3.6
|
%
|
|
$
|
2,418,402
|
|
|
(1)
|
Weighted-Average Coupon and Weighted Average All-in-Yield reflects one-month LIBOR at September 30, 2017, which was
1.23%
.
|
|
(2)
|
Weighted-Average All-in-Yield includes the amortization of deferred origination fees, loan origination costs and accrual of both extension and exit fees.
|
|
|
Average month-end balances for the nine months ended September 30, 2017
|
||||||
|
Description
|
Assets
|
|
Related debt
|
||||
|
First mortgages
|
$
|
2,027,620
|
|
|
$
|
1,173,235
|
|
|
Subordinate loans
(1)
|
1,209,787
|
|
|
—
|
|
||
|
CMBS
|
305,470
|
|
|
233,884
|
|
||
|
|
Three months ended September 30,
|
|
2017 vs. 2016
|
|
Nine months ended September 30,
|
|
2017 vs. 2016
|
||||||||||||||||
|
|
2017
|
|
2016
|
|
$
|
|
2017
|
|
2016
|
|
$
|
||||||||||||
|
Net interest income:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest income from securities
|
$
|
2,625
|
|
|
$
|
8,029
|
|
|
$
|
(5,404
|
)
|
|
$
|
9,247
|
|
|
$
|
23,685
|
|
|
$
|
(14,438
|
)
|
|
Interest income from securities, held to maturity
|
—
|
|
|
2,875
|
|
|
(2,875
|
)
|
|
4,132
|
|
|
8,597
|
|
|
(4,465
|
)
|
||||||
|
Interest income from commercial mortgage loans
|
41,203
|
|
|
27,460
|
|
|
13,743
|
|
|
112,690
|
|
|
72,727
|
|
|
39,963
|
|
||||||
|
Interest income from subordinate loans
|
47,268
|
|
|
32,207
|
|
|
15,061
|
|
|
121,298
|
|
|
89,649
|
|
|
31,649
|
|
||||||
|
Interest expense
|
(19,855
|
)
|
|
(17,256
|
)
|
|
(2,599
|
)
|
|
(56,089
|
)
|
|
(47,620
|
)
|
|
(8,469
|
)
|
||||||
|
Net interest income
|
71,241
|
|
|
53,315
|
|
|
17,926
|
|
|
191,278
|
|
|
147,038
|
|
|
44,240
|
|
||||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
General and administrative expenses
|
(4,629
|
)
|
|
(8,352
|
)
|
|
3,723
|
|
|
(15,587
|
)
|
|
(21,456
|
)
|
|
5,869
|
|
||||||
|
Management fees to related party
|
(8,309
|
)
|
|
(5,903
|
)
|
|
(2,406
|
)
|
|
(23,484
|
)
|
|
(16,374
|
)
|
|
(7,110
|
)
|
||||||
|
Total operating expenses
|
(12,938
|
)
|
|
(14,255
|
)
|
|
1,317
|
|
|
(39,071
|
)
|
|
(37,830
|
)
|
|
(1,241
|
)
|
||||||
|
Income (loss) from unconsolidated joint venture
|
—
|
|
|
80
|
|
|
(80
|
)
|
|
(2,847
|
)
|
|
207
|
|
|
(3,054
|
)
|
||||||
|
Other income
|
359
|
|
|
309
|
|
|
50
|
|
|
710
|
|
|
334
|
|
|
376
|
|
||||||
|
Provision for loan losses and impairments
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,000
|
)
|
|
(15,000
|
)
|
|
10,000
|
|
||||||
|
Realized loss on sale of assets
|
(4,076
|
)
|
|
(225
|
)
|
|
(3,851
|
)
|
|
(5,118
|
)
|
|
(225
|
)
|
|
(4,893
|
)
|
||||||
|
Unrealized gain (loss) on securities
|
13,488
|
|
|
(9,798
|
)
|
|
23,286
|
|
|
11,830
|
|
|
(36,601
|
)
|
|
48,431
|
|
||||||
|
Foreign currency gain (loss)
|
7,763
|
|
|
(4,369
|
)
|
|
12,132
|
|
|
17,848
|
|
|
(21,926
|
)
|
|
39,774
|
|
||||||
|
Bargain purchase gain
|
—
|
|
|
40,021
|
|
|
(40,021
|
)
|
|
—
|
|
|
40,021
|
|
|
(40,021
|
)
|
||||||
|
Gain (loss) on derivative instruments
|
(7,481
|
)
|
|
4,815
|
|
|
(12,296
|
)
|
|
(17,916
|
)
|
|
22,831
|
|
|
(40,747
|
)
|
||||||
|
Net income
|
$
|
68,356
|
|
|
$
|
69,893
|
|
|
$
|
(1,537
|
)
|
|
$
|
151,714
|
|
|
$
|
98,849
|
|
|
$
|
52,865
|
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
|
March 14, 2017
|
March 31, 2017
|
April 17, 2017
|
$0.4600
|
|
June 15, 2017
|
June 30, 2017
|
July 17, 2017
|
$0.4600
|
|
September 14, 2017
|
September 29, 2017
|
October 16, 2017
|
$0.4600
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
|
March 14, 2017
|
March 31, 2017
|
April 17, 2017
|
$0.5391
|
|
June 15, 2017
|
June 30, 2017
|
July 17, 2017
|
$0.5391
|
|
September 14, 2017
|
August 2, 2017
|
August 2, 2017
|
$0.1079
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
|
March 14, 2017
|
March 31, 2017
|
April 17, 2017
|
$0.5000
|
|
June 15, 2017
|
June 30, 2017
|
July 17, 2017
|
$0.5000
|
|
September 14, 2017
|
September 29, 2017
|
October 16, 2017
|
$0.5000
|
|
Declaration Date
|
Record Date
|
Payment Date
|
Amount
|
|
March 14, 2017
|
March 31, 2017
|
April 28, 2017
|
$0.5000
|
|
June 15, 2017
|
June 30, 2017
|
July 31, 2017
|
$0.5000
|
|
September 14, 2017
|
September 29, 2017
|
October 31, 2017
|
$0.5000
|
|
•
|
no investment will be made that would cause the Company to fail to qualify as a REIT for U.S. federal income tax purposes;
|
|
•
|
no investment will be made that would cause the Company to register as an investment company under the Investment Company Act of 1940;
|
|
•
|
investments will be predominantly in the Company’s target assets;
|
|
•
|
no more than 20% of the Company’s cash equity (on a consolidated basis) will be invested in any single investment at the time of the investment;
|
|
•
|
until appropriate investments can be identified, the Manager may invest the proceeds of any offering in interest bearing, short-term investments, including money market accounts and/or funds, that are consistent with the Company’s intention to qualify as a REIT.
|
|
|
Less than 1
year (3) |
|
1 to 3
years (3) |
|
3 to 5
years (3) |
|
More than
5 years |
|
Total
|
||||||||||
|
JPMorgan Facility
(1)
|
$
|
194,500
|
|
|
$
|
700,426
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
894,926
|
|
|
DB Repurchase Facility
(1)
|
10,174
|
|
|
214,400
|
|
|
—
|
|
|
—
|
|
|
224,574
|
|
|||||
|
Goldman Loan
(1)
|
6,291
|
|
|
30,123
|
|
|
—
|
|
|
—
|
|
|
36,414
|
|
|||||
|
DB Facility
|
151,946
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
151,946
|
|
|||||
|
Convertible Senior Notes
|
22,858
|
|
|
285,100
|
|
|
250,727
|
|
|
—
|
|
|
558,685
|
|
|||||
|
Unfunded loan commitments
(2)
|
75,164
|
|
|
5,000
|
|
|
—
|
|
|
—
|
|
|
80,164
|
|
|||||
|
Total
|
$
|
460,933
|
|
|
$
|
1,235,049
|
|
|
$
|
250,727
|
|
|
$
|
—
|
|
|
$
|
1,946,709
|
|
|
|
For the three months ended
September 30, |
|
For the nine
months ended September 30, |
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Net income available to common stockholders
|
$
|
57,208
|
|
|
$
|
60,583
|
|
|
$
|
121,946
|
|
|
$
|
77,864
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
||||||||
|
Equity-based compensation expense
|
2,635
|
|
|
1,828
|
|
|
9,887
|
|
|
5,434
|
|
||||
|
Unrealized (gain) loss on securities
|
(13,488
|
)
|
|
9,798
|
|
|
(11,830
|
)
|
|
36,601
|
|
||||
|
Unrealized (gain) loss on derivative instruments
|
7,481
|
|
|
(4,815
|
)
|
|
17,916
|
|
|
(22,831
|
)
|
||||
|
Foreign Currency (gain) loss, net
|
(7,850
|
)
|
|
4,861
|
|
|
(18,135
|
)
|
|
22,417
|
|
||||
|
Amortization of the Notes related to equity reclassification
|
769
|
|
|
590
|
|
|
1,995
|
|
|
1,745
|
|
||||
|
Income (loss) from unconsolidated joint venture
|
—
|
|
|
(80
|
)
|
|
2,847
|
|
|
(207
|
)
|
||||
|
Provision for loan losses and impairments
|
—
|
|
|
—
|
|
|
5,000
|
|
|
15,000
|
|
||||
|
Series A preferred stock redemption charge
|
3,016
|
|
|
—
|
|
|
3,016
|
|
|
—
|
|
||||
|
Bargain Purchase Gain
|
—
|
|
|
(40,021
|
)
|
|
—
|
|
|
(40,021
|
)
|
||||
|
Realized gain from unconsolidated joint venture
|
—
|
|
|
|
|
346
|
|
|
—
|
|
|||||
|
Total adjustments:
|
(7,437
|
)
|
|
(27,839
|
)
|
|
11,042
|
|
|
18,138
|
|
||||
|
Operating Earnings
|
$
|
49,771
|
|
|
$
|
32,744
|
|
|
$
|
132,988
|
|
|
$
|
96,002
|
|
|
Basic and diluted Operating Earnings per share of common stock
|
$
|
0.47
|
|
|
$
|
0.45
|
|
|
$
|
1.34
|
|
|
$
|
1.38
|
|
|
Basic weighted average shares of common stock outstanding
|
105,446,704
|
|
|
71,919,549
|
|
|
97,546,437
|
|
|
68,913,362
|
|
||||
|
Diluted weighted average shares of common stock outstanding
|
106,812,721
|
|
|
72,861,611
|
|
|
98,919,689
|
|
|
69,865,603
|
|
||||
|
•
|
attempting to structure its financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;
|
|
•
|
using hedging instruments, interest rate swaps and interest rate caps; and
|
|
•
|
to the extent available, using securitization financing to better match the maturity of the Company’s financing with the duration of its assets.
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
3.1
|
|
|
|
|
|
|
|
3.2
|
|
|
|
|
|
|
|
3.3
|
|
|
|
|
|
|
|
3.4
|
|
|
|
|
|
|
|
4.1
|
|
|
|
|
|
|
|
4.2
|
|
|
|
|
|
|
|
4.3
|
|
|
|
|
|
|
|
4.4
|
|
|
|
|
|
|
|
4.5
|
|
|
|
|
|
|
|
4.6
|
|
|
|
|
|
|
|
31.1*
|
|
|
|
|
|
|
|
31.2*
|
|
|
|
|
|
|
|
32.1*
|
|
|
|
101.INS *
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
*
|
Filed herewith
.
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
3.1
|
|
|
|
|
|
|
|
3.2
|
|
|
|
|
|
|
|
3.3
|
|
|
|
|
|
|
|
3.4
|
|
|
|
|
|
|
|
4.1
|
|
|
|
|
|
|
|
4.2
|
|
|
|
|
|
|
|
4.3
|
|
|
|
|
|
|
|
4.4
|
|
|
|
|
|
|
|
4.5
|
|
|
|
|
|
|
|
4.6
|
|
|
|
|
|
|
|
31.1*
|
|
|
|
|
|
|
|
31.2*
|
|
|
|
|
|
|
|
32.1*
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
*
|
Filed herewith.
|
|
|
|
|
APOLLO COMMERCIAL REAL ESTATE FINANCE, INC.
|
|
|
|
|
|
|
November 1, 2017
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Stuart A. Rothstein
|
|
|
|
|
Stuart A. Rothstein
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jai Agarwal
|
|
|
|
|
Jai Agarwal
|
|
|
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
|
(Principal Financial Officer and Principal Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|